Biomet BMET

  1. All
  2. Commentary
  3. Headlines
    1. Zimmer Delivers Solid 3Q, but Still Awaits Antitrust Clearance for Biomet Acquisition

      Commentary

      Thu, 23 Oct 2014

      Nonetheless, we still think greater pricing pressure is now a fixture in the post health-care reform world. We still expect the Biomet deal to close in first quarter of 2015, but would be very surprised if the antitrust regulators did not force Zimmer to make

    2. EU regulators extend Zimmer, Biomet deal deadline to March 11

      Headlines

      Fri, 10 Oct 2014

      BRUSSELS, Oct 10 (Reuters) - European Union antitrust regulators will decide on U.S. medical device maker Zimmer's $13.4 billion bid for Biomet by March 11, a three-week extension from the previous deadline, the European Commission said on Friday.

    3. Zimmer Sees Anemic Domestic Demand Offset by Stronger International Markets in 2Q

      Commentary

      Thu, 24 Jul 2014

      its acquisition of midtier competitor Biomet . Antitrust regulators in Europe and the ..... will close, and we continue to include Biomet in our valuation. With quarterly revenue ..... its spine business with the addition of Biomet . There just is not enough high-quality

    4. KKR Reports Solid 2Q; KFN Acquisition Closes, Boosting Recurring Income Stream

      Commentary

      Thu, 24 Jul 2014

      Blackstone's 8.4%, Carlyle's 5%, and the S&P 500's 4.7% increases. Upcoming sales transactions for US Foods and Biomet will generate more incentive income in the next quarter or two. With the completion of the KFN deal, KKR (at the asset manager

    5. “Tax Reform is Impossible – Until it is Inevitable”

      Headlines

      Tue, 22 Jul 2014

      Biomet moves closer to private territory.

    6. Tides Turn for These Orthopedic Firms

      Headlines

      Mon, 30 Jun 2014

      announcement that Zimmer ZMH plans to acquire Biomet , the competitive dynamics in the orthopedic ..... orthopedic surgeons. Zimmer's acquisition of Biomet removes one midtier competitor from the ..... Economic Moat Rating, and the addition of Biomet (which we had also rated as wide moat

    7. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

      Headlines

      Thu, 26 Jun 2014

      Zimmer 's ZMH "> ZMH credit rating, which we cut to BBB+ from AA on its plan to purchase Biomet for $13.35 billion, including the assumption of Biomet 's $5.5 billion in net debt. Excluding synergies, Zimmer's debt/EBITDA will rise

    8. Orthopedic Competitors Are Circling Smith & Nephew

      Commentary

      Thu, 5 Jun 2014

      After the announcement of Zimmer's plan to acquire midtier rival Biomet , all eyes are on Smith & Nephew as the next target. With hints of Medtronic and Stryker investigating the possibility of purchasing

    9. Smith & Nephew Delivers Anemic First-Quarter Results

      Commentary

      Wed, 7 May 2014

      Against the backdrop of rival Zimmer's planned acquisition of Biomet , we think S&N faces a more difficult task of remaining competitive ..... implant makers will control close to 80% of the market after the Biomet deal closes, and expect most hospitals will want to contract

    10. Smith & Nephew Delivers Anemic First-Quarter Results; No Change to Fair Value Estimate

      Commentary

      Thu, 1 May 2014

      Against the backdrop of rival Zimmer's planned acquisition of Biomet , we think S&N faces a more difficult task of remaining competitive ..... implant makers will control close to 80% of the market after the Biomet deal closes, and expect most hospitals will want to contract

    « Prev12345Next »
    Content Partners